Published in Drug Week, April 15th, 2005
According to recent research published in the journal Cancer Research, "Although screening for large deletions or duplications of the BRCA1 gene is becoming a routine component of the molecular diagnosis of familial breast cancer, little is known about the occurrence of such rearrangements in the BRCA2 gene.
"Because of the high frequency of BRCA2 mutations in breast cancer families with at least one case of male breast cancer,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week